Literature DB >> 17103037

Clostridium difficile-associated pouchitis.

Bo Shen1, John R Goldblum, Tracy L Hull, Feza H Remzi, Ana E Bennett, Victor W Fazio.   

Abstract

Pouchitis is the most common long-term sequela of ileal pouch-anal anastomosis (IPAA) following total proctocolectomy. No single pathogen is identified as being solely responsible for the pathogenesis of the disease. Here we describe a case of Clostridium difficile-associated pouchitis that was successfully treated with ciprofloxacin and tinidazole. Diagnosis and management of a patient with medically refractory pouchitis associated with Clostridium difficile infection is described. A 63-year-old male with underlying ulcerative colitis and IPAA presented with increased stool frequency and seepage for 2 months, which partially responded to oral metronidazole. While on the antibiotic therapy, pouch endoscopy was performed and showed severe pouchitis. Assays for Clostridium difficile toxins in stool specimens were positive. He was treated with a 4-week course of ciprofloxacin 500 mg BID and tinidazole 500 mg TID. His symptoms resolved within several days from the initiation of therapy. A repeat pouch endoscopy at week 5 showed a complete resolution of mucosal inflammation of the pouch, while tests for Clostridium difficile toxins became negative. Clostridium difficile-associated pouchitis is rare. However, Clostridium difficile infection should be excluded in patients with chronic refractory pouchitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17103037     DOI: 10.1007/s10620-006-9172-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  21 in total

1.  Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis.

Authors:  Bo Shen; Victor W Fazio; Feza H Remzi; Aaron Brzezinski; Ana E Bennett; Rocio Lopez; Jeffrey P Hammel; Jean-Paul Achkar; Charles L Bevins; Ian C Lavery; Scott A Strong; Conor P Delaney; Wendy Liu; Marlene L Bambrick; Kerry K Sherman; Bret A Lashner
Journal:  Clin Gastroenterol Hepatol       Date:  2006-01       Impact factor: 11.382

2.  Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.

Authors:  A M Jokipii; L Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 3.  Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment.

Authors:  W J Sandborn
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

4.  Isolation of Clostridium difficile from the small bowel.

Authors:  R H Taylor; S P Borriello; A J Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-08

5.  Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis.

Authors:  S Chaussade; Y Denizot; P Valleur; J Nicoli; P Raibaud; J Guerre; P Hautefeuille; D Couturier; J Benveniste
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

6.  Pseudomembranous enteritis after proctocolectomy: report of a case.

Authors:  Z Vesoulis; G Williams; B Matthews
Journal:  Dis Colon Rectum       Date:  2000-04       Impact factor: 4.585

7.  Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.

Authors:  Grit Ackermann; Angelika Degner; Stuart H Cohen; Joseph Silva; Arne C Rodloff
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

8.  Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis.

Authors:  Livia Biancone; Giampiero Palmieri; Antonella Lombardi; Alfredo Colantoni; Francesco Tonelli; Kiron Moy Das; Francesco Pallone
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

9.  Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease.

Authors:  S Meyers; L Mayer; E Bottone; E Desmond; H D Janowitz
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682

10.  Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.

Authors:  M Duffy; L O'Mahony; J C Coffey; J K Collins; F Shanahan; H P Redmond; W O Kirwan
Journal:  Dis Colon Rectum       Date:  2002-03       Impact factor: 4.585

View more
  15 in total

1.  Obesity Is Associated with Decreased Risk of Clostridium difficile Infection in Hospitalized Patients with Pouchitis.

Authors:  Falgun Gosai; Fahrettin Covut; Mohammad Alomari; Asif Hitawala; Amandeep Singh; Gaurav Kisangani; Rocio Lopez; Bo Shen
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

Review 2.  Microbial host interactions in IBD: implications for pathogenesis and therapy.

Authors:  R Balfour Sartor; Marcus Muehlbauer
Journal:  Curr Gastroenterol Rep       Date:  2007-12

3.  Clostridium difficile infection: risk factors, diagnosis and management.

Authors:  Christina M Surawicz
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

4.  Innate immune environment in ileal pouch mucosa: α5 defensin up-regulation as predictor of chronic/relapsing pouchitis.

Authors:  Marco Scarpa; Alessia Grillo; Melania Scarpa; Paola Brun; Carlo Castoro; Anna Pozza; Donatella Cavallo; Diego Faggian; Cesare Ruffolo; Renata D'Incà; Romeo Bardini; Ignazio Castagliuolo; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2011-10-08       Impact factor: 3.452

5.  Diagnosis and treatment of pouchitis.

Authors:  Bo Shen; Bret A Lashner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-05

6.  Catastrophic Clostridium difficile enteritis in a pelvic pouch patient: report of a case.

Authors:  Michael J Wood; Neil Hyman; James C Hebert; Hagen Blaszyk
Journal:  J Gastrointest Surg       Date:  2007-12-11       Impact factor: 3.452

7.  Recent developments on the role of Clostridium difficile in inflammatory bowel disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 8.  Fulminant Clostridium difficile-associated pouchitis with a fatal outcome.

Authors:  Bo Shen; Feza H Remzi; Victor W Fazio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 46.802

Review 9.  Pouchitis.

Authors:  En-Da Yu; Zhuo Shao; Bo Shen
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

Review 10.  Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review.

Authors:  Anca Trifan; Carol Stanciu; Oana Stoica; Irina Girleanu; Camelia Cojocariu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.